ecogenesis biopolymers
A biomaterial engineering and sustainable product development studio that commercializes plant-based biopolymers, specifically PHA (polyhydroxyalkanoate) and plant-based TPU (thermoplastic polyurethane) for 3D printing, packaging, and industrial manufacturing applications.
- Team Size
- 2-10
- Stage
- Active
- Total Funding
- $1M
- Latest Round
- Seed
- Key Investors
- Pointe Angels
Technology & Products
Key Products
["genTPU plant-based TPU filament (95A and 60D hardness)","genPHA biopolymer filament for 3D printing","Custom PHA formulations for injection molding applications","Custom PHA formulations for blow molding applications","Soleic® TPU distribution (Algenesis partnership)","Biopolymer commercialization consulting services","On-site trial execution and technical support"]
Technological Advantage
Leverages 35+ years of experience in traditional plastic manufacturing to overcome the commercialization challenges specific to biopolymers - understanding rheological property variations across suppliers, optimizing formulations for specific end-use applications, and providing on-site technical support for injection molding, blow molding, and extrusion processes. Offers proven ability to rapidly commercialize sustainable materials, demonstrated by launching genTPU filament in under 2 months from concept to market through partnership collaboration.
Differentiation
Value Proposition
Combines 35+ years of traditional plastics commercialization expertise with sustainable biomaterials engineering to help manufacturers transition to fully biodegradable alternatives without compromising performance or production efficiency, providing end-to-end support from material selection through on-site trial execution.
How They Differentiate
Only company publicly listing full ingredient transparency for biopolymer products; combines 35+ years of traditional plastics commercialization expertise with proprietary PHA and plant-based TPU formulations; provides full-service biomaterial commercialization support from material selection through on-site trial execution; exclusive worldwide distributor for Algenesis Soleic TPU in 3D printing market; demonstrated rapid commercialization capability with 2-month concept-to-market timeline.
Market & Competition
Target Customers
3D printing professionals and hobbyists, industrial manufacturers requiring sustainable materials, packaging companies, brand owners seeking biodegradable product solutions, and converters needing expert biopolymer commercialization support
Industry Verticals
["Additive Manufacturing/3D Printing","Sustainable Packaging","Industrial Manufacturing","Consumer Goods","Biomaterials","Plastics Processing"]
Competitors
ColorFabb (Netherlands); B4Plastics (Belgium); Algenesis/Soleic (San Diego, CA)
Growth & Milestones
Growth Metrics
Early commercial stage with products available on Amazon; rapid product development cycle (<2 months concept-to-market); expanding distribution partnerships; European market entry planned for 2026
Major Milestones
["Company founded in 2024 by Fred Pinczuk and Darlene Barbee in Costa Mesa, California","November 21, 2024: Announced exclusive partnership with Algenesis for worldwide 3D printing market distribution of Soleic plant-based TPU","2025: Launched genPHA third-generation PHA biopolymer filament for 3D printing","April 2025: Named US distributor for Fluxo Technologies' Plexint CPLA for selective laser sintering (SLS) platforms","December 2025: Launched genTPU plant-based TPU filament (95A and 60D hardness) derived from algae and plant oils with 77.8-83.8% CO2 footprint reduction","Products available on Amazon marketplace for direct-to-consumer sales","European distribution partnership planned for announcement Q1 2026 with market entry by summer 2026"]
Notable Customers
Amazon marketplace customers (genTPU, genPHA filaments); 3D printing professionals and hobbyists; Fluxo Technologies (distribution partnership for Plexint CPLA in US SLS market)